JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$3.46B |
| 2 |
Microsoft
MSFT
|
+$2.83B |
| 3 |
Eli Lilly
LLY
|
+$2.1B |
| 4 |
Broadcom
AVGO
|
+$1.33B |
| 5 |
Stryker
SYK
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$3.18B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$2.39B |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.35B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$2.07B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.04% |
| 2 | Technology | 20.48% |
| 3 | Healthcare | 9.65% |
| 4 | Financials | 9.27% |
| 5 | Consumer Discretionary | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4901
ThredUp
TDUP
$285M
| $291K | ﹤0.01% |
129,522
+18,619
| +17% | +$48.4K |
2021 Q1
11 quarters
|
|
4902
Dimensional International Small Cap ETF
DFIS
$5.78B
| $289K | ﹤0.01% |
+11,975
| New | +$266K |
2023 Q4
0 quarters
|
|
4903
Nano X Imaging
NNOX
$50M
| $289K | ﹤0.01% |
45,414
+1,465
| +3% | +$9.15K |
2020 Q4
12 quarters
|
|
4904
Direxion Daily Financial Bull 3x ETF
FAS
$1.85B
| $289K | ﹤0.01% |
3,499
-794
| -18% | -$52.1K |
2023 Q2
2 quarters
|
|
|
SOHU
4905
Sohu.com
SOHU
$325M
| $289K | ﹤0.01% |
29,107
-2,752
| -9% | -$24.6K |
2015 Q4
32 quarters
|
|
4906
Arbutus Biopharma
ABUS
$882M
| $289K | ﹤0.01% |
115,479
-3,521
| -3% | -$6.9K |
2020 Q4
12 quarters
|
|
4907
Columbia India Consumer ETF
INCO
$206M
| $287K | ﹤0.01% |
+4,880
| New | +$272K |
2023 Q4
0 quarters
|
|
|
FLD
4908
Fold Holdings
FLD
$29.7M
| $287K | ﹤0.01% |
27,121
+4,304
| +19% | +$45.2K |
2023 Q3
1 quarter
|
|
4909
Invesco MSCI Sustainable Future ETF
ERTH
$123M
| $286K | ﹤0.01% |
6,053
-1,493
| -20% | -$63.7K |
2021 Q4
8 quarters
|
|
|
SWAV
4910
CALL
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $286K | ﹤0.01% |
1,500
| – | – |
2023 Q2
2 quarters
|
|
4911
Anterix
ATEX
$1.65B
| $285K | ﹤0.01% |
8,555
-292
| -3% | -$9.42K |
2017 Q4
24 quarters
|
|
4912
Sutro Biopharma
STRO
$255M
| $284K | ﹤0.01% |
6,614
-1,068
| -14% | -$33.9K |
2018 Q3
21 quarters
|
|
4913
PUT
Mirum Pharmaceuticals
MIRM
$5.38B
| $283K | ﹤0.01% |
+9,600
| New | +$291K |
2023 Q4
0 quarters
|
|
|
SEMR
4914
DELISTED
Semrush
SEMR
| $283K | ﹤0.01% |
20,730
-6,678
| -24% | -$66K |
2021 Q4
8 quarters
|
|
4915
Sinclair Inc
SBGI
$899M
| $283K | ﹤0.01% |
21,723
-21,513
| -50% | -$264K |
2013 Q2
42 quarters
|
|
|
CTLP
4916
DELISTED
Cantaloupe
CTLP
| $283K | ﹤0.01% |
38,144
-1,077
| -3% | -$7.44K |
2020 Q4
12 quarters
|
|
4917
American Well
AMWL
$211M
| $283K | ﹤0.01% |
9,482
-5,912
| -38% | -$145K |
2020 Q3
13 quarters
|
|
|
YMAB
4918
DELISTED
Y-mAbs Therapeutics
YMAB
| $282K | ﹤0.01% |
41,364
+8,841
| +27% | +$51.1K |
2018 Q3
21 quarters
|
|
4919
Paysafe
PSFE
$281M
| $281K | ﹤0.01% |
22,009
-669
| -3% | -$7.39K |
2021 Q1
11 quarters
|
|
|
NEXN
4920
Nexxen International
NEXN
$502M
| $281K | ﹤0.01% |
55,462
+14,632
| +36% | +$56.3K |
2021 Q2
10 quarters
|
|
4921
PUT
McCormick & Company Non-Voting
MKC
$12B
| $281K | ﹤0.01% |
+4,100
| New | +$268K |
2023 Q4
0 quarters
|
|
4922
Nuveen ESG Emerging Markets Equity ETF
NUEM
$435M
| $280K | ﹤0.01% |
10,404
+6,908
| +198% | +$181K |
2022 Q4
4 quarters
|
|
4923
Commercial Vehicle Group
CVGI
$120M
| $280K | ﹤0.01% |
39,978
+1,586
| +4% | +$10.8K |
2020 Q3
13 quarters
|
|
4924
Invesco Oil & Gas Services ETF
PXJ
$130M
| $280K | ﹤0.01% |
+9,755
| New | +$285K |
2023 Q4
0 quarters
|
|
|
TELL
4925
DELISTED
Tellurian Inc.
TELL
| $279K | ﹤0.01% |
369,199
-326,086
| -47% | -$231K |
2017 Q4
24 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2023 Portfolio in Review
As of Q4 2023, JP Morgan Chase held 8,129 positions worth $1.04T, up 15% from $906B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
JP Morgan Chase's Q4 2023 filing shows 701 new, 3,661 increased, 2,247 reduced and 617 closed positions. Its largest new stake was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M. The largest sale was Vanguard S&P 500 ETF, an estimated $3.18B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2023 buy was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M.
- JP Morgan Chase added most to Vanguard Intermediate-Term Corporate Bond ETF in Q4 2023, an estimated $3.46B increase.
- JP Morgan Chase's biggest Q4 2023 reduction was Vanguard S&P 500 ETF, cutting an estimated $3.18B.
- JP Morgan Chase fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
- JP Morgan Chase's ten largest holdings make up 20% of its $1.04T portfolio in Q4 2023.
- JP Morgan Chase opened 701 new positions and closed 617 in Q4 2023.
- JP Morgan Chase's portfolio value rose 15% quarter-over-quarter to $1.04T.
Based on JP Morgan Chase's 13F filing for Q4 2023, filed 12 Feb 2024.